Boston, Mass. (PRWEB) September 19, 2013
Sanofi and its Cambridge-based biotechnology company, Genzyme, today announced a new partnership and $1 million gift to support student success programs in the University of Massachusetts Boston’s College of Science and Mathematics (CSM). The announcement of the gift was made at the opening of Sanofi’s new R&D facility at 640 Memorial Drive in Cambridge, which will be focused on cancer research.
“We thank and recognize Sanofi and Genzyme for sharing our vision for student success in science, technology, engineering, and mathematics (STEM) and for their partnership with UMass Boston students and the future of Greater Boston,” said Chancellor J. Keith Motley.
“Supporting the Commonwealth's goal of continued leadership in scientific and technological innovation, CSM is providing its students with an outstanding academic experience that enhances their prospects for careers in STEM fields. This investment in UMass Boston students by Genzyme and Sanofi, which extends an existing partnership, represents an outstanding example of how collaboration between a public higher education institution and a major corporation can have a significant impact on developing a vibrant STEM workforce.”
Genzyme and Sanofi target their philanthropic giving toward areas of need in communities, with particular focus on science and education, including organizations that foster the next generation of diverse STEM leaders. The College of Science and Mathematics has developed a highly successful program for advancing student success in STEM majors. This program revamped advising, academic support, and orientation, and developed a learning community program as the centerpiece of this strategy. Retention in the program is more than 15 points above the college’s preexisting levels, with large increases of students remaining in STEM majors.
“This partnership means that together, we
Copyright©2012 Vocus, Inc.
All rights reserved